162 related articles for article (PubMed ID: 32773898)
1. Registration of antimicrobials, Kenya, Uganda and United Republic of Tanzania, 2018.
Lyus R; Pollock A; Ocan M; Brhlikova P
Bull World Health Organ; 2020 Aug; 98(8):530-538. PubMed ID: 32773898
[TBL] [Abstract][Full Text] [Related]
2. Registration of essential medicines in Kenya, Tanzania and Uganda: a retrospective analysis.
Green A; Lyus R; Ocan M; Pollock AM; Brhlikova P
J R Soc Med; 2023 Oct; 116(10):331-342. PubMed ID: 37343667
[TBL] [Abstract][Full Text] [Related]
3. Bridging the gap? Local production of medicines on the national essential medicine lists of Kenya, Tanzania and Uganda.
Baldeh AO; Millard C; Pollock AM; Brhlikova P
J Pharm Policy Pract; 2023 Jan; 16(1):18. PubMed ID: 36717871
[TBL] [Abstract][Full Text] [Related]
4. Access to essential cancer medicines for children: a comparative mixed-methods analysis of availability, price, and health-system determinants in east Africa.
Petricca K; Kambugu J; Githang'a J; Macharia WM; Njuguna F; McLigeyo A; Nyangasi M; Orem J; Kanyamuhunga A; Laiti R; Katabalo D; Schroeder K; Rogo K; Maguire B; Wambui L; Nkurunziza JN; Wong B; Neposlan J; Kilawe L; Gupta S; Denburg AE
Lancet Oncol; 2023 May; 24(5):563-576. PubMed ID: 37023781
[TBL] [Abstract][Full Text] [Related]
5. Audit of essential medicine listing and registration status of medicines on standard treatment guidelines in Kenya, Tanzania and Uganda: Case study of malaria, tuberculosis, hypertension and type 2 diabetes mellitus.
Babatunde D; Pollock AM; Ocan M; Brhlikova P
JRSM Open; 2024 Mar; 15(3):20542704241232814. PubMed ID: 38560365
[TBL] [Abstract][Full Text] [Related]
6. The role of government agencies and other actors in influencing access to medicines in three East African countries.
Odoch WD; Dambisya Y; Peacocke E; Sandberg KI; Hembre BSH
Health Policy Plan; 2021 Apr; 36(3):312-321. PubMed ID: 33569583
[TBL] [Abstract][Full Text] [Related]
7. Supply-chain factors and antimicrobial stewardship.
Kamere N; Rutter V; Munkombwe D; Aywak DA; Muro EP; Kaminyoghe F; Rajab K; Lawal MO; Muriithi N; Kusu N; Karimu O; Barlatt SHA; Nambatya W; Ashiru-Oredope D
Bull World Health Organ; 2023 Jun; 101(6):403-411. PubMed ID: 37265674
[TBL] [Abstract][Full Text] [Related]
8. Comparison of antibiotics included in national essential medicines lists of 138 countries using the WHO Access, Watch, Reserve (AWaRe) classification: a cross-sectional study.
Adekoya I; Maraj D; Steiner L; Yaphe H; Moja L; Magrini N; Cooke G; Loeb M; Persaud N
Lancet Infect Dis; 2021 Oct; 21(10):1429-1440. PubMed ID: 34332706
[TBL] [Abstract][Full Text] [Related]
9. National Consumption of Antimicrobials in Tanzania: 2017-2019.
Mbwasi R; Mapunjo S; Wittenauer R; Valimba R; Msovela K; Werth BJ; Khea AM; Nkiligi EA; Lusaya E; Stergachis A; Konduri N
Front Pharmacol; 2020; 11():585553. PubMed ID: 33192526
[No Abstract] [Full Text] [Related]
10. What happened to anti-malarial markets after the Affordable Medicines Facility-malaria pilot? Trends in ACT availability, price and market share from five African countries under continuation of the private sector co-payment mechanism.
; Tougher S; Hanson K; Goodman C
Malar J; 2017 Apr; 16(1):173. PubMed ID: 28441956
[TBL] [Abstract][Full Text] [Related]
11. Service readiness of health facilities in Bangladesh, Haiti, Kenya, Malawi, Namibia, Nepal, Rwanda, Senegal, Uganda and the United Republic of Tanzania.
Leslie HH; Spiegelman D; Zhou X; Kruk ME
Bull World Health Organ; 2017 Nov; 95(11):738-748. PubMed ID: 29147054
[TBL] [Abstract][Full Text] [Related]
12. WHO's essential medicines and AWaRe: recommendations on first- and second-choice antibiotics for empiric treatment of clinical infections.
Moja L; Zanichelli V; Mertz D; Gandra S; Cappello B; Cooke GS; Chuki P; Harbarth S; Pulcini C; Mendelson M; Tacconelli E; Ombajo LA; Chitatanga R; Zeng M; Imi M; Elias C; Ashorn P; Marata A; Paulin S; Muller A; Aidara-Kane A; Wi TE; Were WM; Tayler E; Figueras A; Da Silva CP; Van Weezenbeek C; Magrini N; Sharland M; Huttner B; Loeb M
Clin Microbiol Infect; 2024 Apr; 30 Suppl 2():S1-S51. PubMed ID: 38342438
[TBL] [Abstract][Full Text] [Related]
13. Access to and Affordability of World Health Organization Essential Medicines for Cancer in Sub-Saharan Africa: Examples from Kenya, Rwanda, and Uganda.
Kizub DA; Naik S; Abogan AA; Pain D; Sammut S; Shulman LN; Martei YM
Oncologist; 2022 Nov; 27(11):958-970. PubMed ID: 36094141
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial consumption surveillance in Uganda: Results from an analysis of national import data for the human health sector, 2018-2021.
Murungi M; Ndagije HB; Kiggundu R; Kesi DN; Waswa JP; Rajab K; Barigye M; Serwanga A; Manirakiza L; Kasujja H; Kaweesi D; Joshi MP; Namugambe J; Konduri N
J Infect Public Health; 2023 Dec; 16 Suppl 1():45-51. PubMed ID: 37926595
[TBL] [Abstract][Full Text] [Related]
15. The role of multidimensional poverty in antibiotic misuse: a mixed-methods study of self-medication and non-adherence in Kenya, Tanzania, and Uganda.
Green DL; Keenan K; Fredricks KJ; Huque SI; Mushi MF; Kansiime C; Asiimwe B; Kiiru J; Mshana SE; Neema S; Mwanga JR; Kesby M; Lynch AG; Worthington H; Olamijuwon E; Abed Al Ahad M; Aduda A; Njeru JM; Mmbaga BT; Bazira J; Sandeman A; Stelling J; Gillespie SH; Kibiki G; Sabiiti W; Sloan DJ; Holden MTG;
Lancet Glob Health; 2023 Jan; 11(1):e59-e68. PubMed ID: 36521953
[TBL] [Abstract][Full Text] [Related]
16. Effects of scaling up various community-level interventions on child mortality in Burundi, Kenya, Rwanda, Uganda and Tanzania: a modeling study.
Hategeka C; Tuyisenge G; Bayingana C; Tuyisenge L
Glob Health Res Policy; 2019; 4():1. PubMed ID: 31168481
[TBL] [Abstract][Full Text] [Related]
17. Evidence on access to medicines for chronic diseases from household surveys in five low- and middle-income countries.
Vialle-Valentin CE; Serumaga B; Wagner AK; Ross-Degnan D
Health Policy Plan; 2015 Oct; 30(8):1044-52. PubMed ID: 25255920
[TBL] [Abstract][Full Text] [Related]
18. Costing of HIV services, Uganda and United Republic of Tanzania.
McBain RK; Jordan M; Kapologwe NA; Kagaayi J; Kiracho EE; Nandakumar AK
Bull World Health Organ; 2023 Oct; 101(10):626-636. PubMed ID: 37772194
[TBL] [Abstract][Full Text] [Related]
19. Pathways to increased coverage: an analysis of time trends in contraceptive need and use among adolescents and young women in Kenya, Rwanda, Tanzania, and Uganda.
Dennis ML; Radovich E; Wong KLM; Owolabi O; Cavallaro FL; Mbizvo MT; Binagwaho A; Waiswa P; Lynch CA; Benova L
Reprod Health; 2017 Oct; 14(1):130. PubMed ID: 29041936
[TBL] [Abstract][Full Text] [Related]
20. Applying the iDARE Methodology in Uganda, Kenya, and Tanzania to Improve Health Outcomes During the COVID-19 Pandemic.
Ottosson A; Draru J; Mwanzi L; Mwita SK; Pappa S; Odom K; Faramand TH
Glob Health Sci Pract; 2022 Jun; 10(3):. PubMed ID: 36332068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
